Please login to the form below

Not currently logged in
Email:
Password:

severe hypertriglyceridemia

This page shows the latest severe hypertriglyceridemia news and features for those working in and with pharma, biotech and healthcare.

AZ target Omthera files blood fat drug in US

FDA submission for Epanova in severe hypertriglyceridemia. Omthera Pharmaceuticals said yesterday it had submitted its drug Epanova for US approval in the treatment of patients with high levels of the blood ... The company, which is the subject of a

Latest news

  • AstraZeneca offers $443m to buy Omthera AstraZeneca offers $443m to buy Omthera

    In trials, the product has been shown to reduce triglyceride levels and improve other blood lipid profiles and is due to be filed for approval for severe hypertriglyceridemia in the coming

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics